We are live on ! Find out more
SP

Sarasin & Partners Portfolio holdings

AUM $8.54B
1-Year Est. Return 9.6%
This Fund
S&P 500
This Quarter Est. Return
+13.36%
1 Year Est. Return
+9.6%
3 Year Est. Return
+77.95%
5 Year Est. Return
+86.04%
10 Year Est. Return
+393.05%
AUM
$9.1B
AUM Growth
+$1.09B
Cap. Flow
+$60.9M
Cap. Flow %
0.67%
Top 10 Hldgs %
45.34%
Holding
89
New
10
Increased
23
Reduced
45
Closed
5

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$139M
2
NVDA icon
NVIDIA
NVDA
+$113M
3
AMT icon
American Tower
AMT
+$59.5M
4
TTEK icon
Tetra Tech
TTEK
+$30.2M
5
AMZN icon
Amazon
AMZN
+$29.7M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$74.1M
2
ILMN icon
Illumina
ILMN
+$58.5M
3
CME icon
CME Group
CME
+$49.8M
4
MRK icon
Merck
MRK
+$45.6M
5
DIS icon
Walt Disney
DIS
+$36.2M

Sector Composition

Rank Sector Weight
1 Technology 22.27%
2 Financials 14%
3 Healthcare 12.16%
4 Consumer Discretionary 11.82%
5 Industrials 11.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
1
Amazon
AMZN
$2.53T
$628M 6.9%
4,132,653
+211,574
+5% +$29.7M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.08T
$570M 6.27%
4,083,652
-134,749
-3% -$18.1M
MSFT icon
3
Microsoft
MSFT
$3.35T
$536M 5.89%
1,425,758
-71,240
-5% -$25.4M
CME icon
4
CME Group
CME
$96.1B
$475M 5.22%
2,253,967
-233,174
-9% -$49.8M
TSM icon
5
TSMC
TSM
$2.09T
$381M 4.19%
3,665,463
-286,995
-7% -$27.4M
AMGN icon
6
Amgen
AMGN
$209B
$331M 3.63%
1,147,693
-36,118
-3% -$9.84M
CL icon
7
Colgate-Palmolive
CL
$73.3B
$323M 3.55%
4,053,634
+49,980
+1% +$3.76M
MRK icon
8
Merck
MRK
$321B
$312M 3.43%
2,857,795
-439,635
-13% -$45.6M
MA icon
9
Mastercard
MA
$510B
$307M 3.37%
719,125
-25,075
-3% -$10.1M
OTIS icon
10
Otis Worldwide
OTIS
$27.3B
$262M 2.88%
2,923,073
-23,715
-0.8% -$1.97M
AMT icon
11
American Tower
AMT
$81.3B
$260M 2.86%
1,204,495
+314,970
+35% +$59.5M
DE icon
12
Deere & Co
DE
$162B
$250M 2.75%
625,123
-150
-0% -$56.6K
AAPL icon
13
Apple
AAPL
$4.9T
$241M 2.65%
1,250,309
+57,840
+5% +$10.7M
ECL icon
14
Ecolab
ECL
$78.6B
$233M 2.57%
1,176,517
-63,015
-5% -$11.3M
TMO icon
15
Thermo Fisher Scientific
TMO
$214B
$221M 2.43%
416,115
+50,372
+14% +$24.4M
DIS icon
16
Walt Disney
DIS
$167B
$209M 2.3%
2,317,958
-410,219
-15% -$36.2M
NVDA icon
17
NVIDIA
NVDA
$4.72T
$209M 2.3%
4,217,080
+2,445,480
+138% +$113M
TTEK icon
18
Tetra Tech
TTEK
$8.31B
$204M 2.24%
6,109,640
+945,245
+18% +$30.2M
HD icon
19
Home Depot
HD
$332B
$204M 2.24%
588,127
+23,831
+4% +$7.38M
PLD icon
20
Prologis
PLD
$136B
$201M 2.21%
1,510,873
+233,881
+18% +$26.6M
META icon
21
Meta Platforms (Facebook)
META
$1.37T
$194M 2.13%
547,649
+19,305
+4% +$6.29M
AVGO icon
22
Broadcom
AVGO
$1.85T
$190M 2.09%
1,702,590
-782,730
-31% -$74.1M
COST icon
23
Costco
COST
$423B
$180M 1.98%
272,213
+15,238
+6% +$9.03M
CSCO icon
24
Cisco
CSCO
$448B
$174M 1.92%
3,453,145
+4,582
+0.1% +$234K
HDB icon
25
HDFC Bank
HDB
$124B
$174M 1.91%
5,182,750
+20,798
+0.4% +$627K

Similar funds

Sarasin & Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Sarasin & Partners held 89 positions worth $9.1B, up 14% from $8.01B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Sarasin & Partners's Q4 2023 filing shows 10 new, 23 increased, 45 reduced and 5 closed positions. Its largest new stake was Mercado Libre: 15,366 shares worth $24.1M. The largest sale was Broadcom, an estimated $74.1M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Sarasin & Partners's largest Q4 2023 buy was Mercado Libre: 15,366 shares worth $24.1M.
  • Sarasin & Partners added most to Eli Lilly in Q4 2023, an estimated $139M increase.
  • Sarasin & Partners's biggest Q4 2023 reduction was Broadcom, cutting an estimated $74.1M.
  • Sarasin & Partners fully exited Illumina in Q4 2023, selling an estimated $58.5M.
  • Sarasin & Partners's ten largest holdings make up 45% of its $9.1B portfolio in Q4 2023.
  • Sarasin & Partners opened 10 new positions and closed 5 in Q4 2023.
  • Sarasin & Partners's portfolio value rose 14% quarter-over-quarter to $9.1B.

Based on Sarasin & Partners's 13F filing for Q4 2023, filed 10 Jan 2024.